Published in Mol Pharmacol on February 01, 1994
Molecular Architecture of G Protein-Coupled Receptors. Drug Dev Res (1996) 1.39
The C9 methyl group of retinal interacts with glycine-121 in rhodopsin. Proc Natl Acad Sci U S A (1997) 1.14
Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron (2012) 1.06
The pharmacology of neurokinin receptors in addiction: prospects for therapy. Subst Abuse Rehabil (2015) 0.77
Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain. J Pharmacol Exp Ther (1995) 0.75
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature (1995) 5.15
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell (1999) 4.97
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science (1997) 3.84
The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73
Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem (2001) 3.49
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Expression and biologic characterization of the murine chemokine KC. J Immunol (1995) 2.66
Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) (1988) 2.64
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science (1997) 2.58
C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol (1994) 2.57
HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem (1997) 2.55
Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol (1997) 2.35
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Neurogenic amplification of immune complex inflammation. Science (1996) 2.05
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J Biol Chem (2001) 2.00
De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry (2013) 1.93
CD4-independent binding of SIV gp120 to rhesus CCR5. Science (1997) 1.87
Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett (1987) 1.86
Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med (1997) 1.83
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J Biol Chem (2000) 1.80
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem (1994) 1.72
Somatostatin cell processes as pathways for paracrine secretion. Science (1979) 1.69
Pancreatic polypeptide: a hormone under vagal control. Gastroenterology (1983) 1.64
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
The processing of peptide precursors. 'Proline-directed arginyl cleavage' and other monobasic processing mechanisms. FEBS Lett (1986) 1.59
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med (1998) 1.59
Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest (1998) 1.57
Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet (1976) 1.56
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J (1998) 1.54
Neutral endopeptidase modulation of septic shock. J Exp Med (1995) 1.53
The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Mol Biol Cell (2001) 1.52
Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest (1997) 1.51
[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci U S A (1990) 1.50
Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett (1998) 1.49
Differential regulation of CXCR4 and CCR5 endocytosis. J Cell Sci (1998) 1.49
Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J Biol Chem (2000) 1.49
The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr Opin Immunol (1994) 1.47
Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett (1990) 1.45
Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol (1999) 1.43
Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics (1992) 1.42
The effect of pH on beta(2) adrenoceptor function. Evidence for protonation-dependent activation. J Biol Chem (2000) 1.40
Defining proximity relationships in the tertiary structure of the dopamine transporter. Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn(2+)-binding site. J Biol Chem (1999) 1.39
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci U S A (1993) 1.36
The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem (1992) 1.34
BAR domains, amphipathic helices and membrane-anchored proteins use the same mechanism to sense membrane curvature. FEBS Lett (2010) 1.33
The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med (1997) 1.31
Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J Biol Chem (1999) 1.29
Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept (1984) 1.26
Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol (1986) 1.26
Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. J Biol Chem (1998) 1.25
Specific interactions of chemoattractant factor receptors with G-proteins. J Biol Chem (1993) 1.25
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med (2000) 1.24
Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. Mol Pharmacol (2001) 1.22
Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. Nature (1993) 1.21
Water transport by the human Na+-coupled glutamate cotransporter expressed in Xenopus oocytes. J Physiol (2001) 1.19
Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. J Biol Chem (1993) 1.19
Structure and function of the murine chemokine receptor CXCR3. Eur J Immunol (1999) 1.18
Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. Proc Natl Acad Sci U S A (1999) 1.16
Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. J Pharmacol Exp Ther (2001) 1.16
Peptidase modulation of the pulmonary effects of tachykinins in tracheal superfused guinea pig lungs. J Clin Invest (1990) 1.15
Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol (2002) 1.14
The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci (1997) 1.14
Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors. J Med Chem (1998) 1.14
Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. Nature (1995) 1.14
Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest (2001) 1.12
Cephalic phase of pancreatic-polypeptide secretion studied by sham feeding in man. Scand J Gastroenterol (1979) 1.11
Y1 and Y2 receptors for neuropeptide Y. FEBS Lett (1989) 1.10
Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes. J Biol Chem (1994) 1.09
Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett (1990) 1.09
Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem (1994) 1.08
Virally encoded 7TM receptors. Oncogene (2001) 1.07
Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics. Br Med J (1979) 1.07
Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature (1980) 1.05
Isolation and biogenesis of a new peptide from pancreatic islets. Nature (1981) 1.04
Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines. J Biol Chem (1989) 1.04
PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv Exp Med Biol (1996) 1.04
Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. Mol Pharmacol (1999) 1.04
A cDNA encoding a small common precursor for human pancreatic polypeptide and pancreatic icosapeptide. EMBO J (1984) 1.03
Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J Exp Med (2001) 1.02
Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. J Immunol (2000) 1.02
Synchronous oscillations in the basal secretion of pancreatic-polypeptide and gastric acid. Depression by cholinergic blockade of pancreatic-polypeptide concentrations in plasma. Gastroenterology (1979) 1.00
Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J Biol Chem (2001) 1.00
Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor. Mol Pharmacol (1998) 0.99
Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine. Mol Pharmacol (1995) 0.99
Vagal slowing of the heart during haemorrhage: observations from 20 consecutive hypotensive patients. Br Med J (Clin Res Ed) (1986) 0.98
Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain. J Biochem (2000) 0.98
Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor. Mol Pharmacol (2000) 0.98
Use of NK(1) knockout mice to analyze substance P-induced edema formation. Am J Physiol (1999) 0.98
Structural interactions between chemokine receptors, gp120 Env and CD4. Semin Immunol (1998) 0.98
Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Am J Pathol (2000) 0.97
Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J Immunol (1998) 0.97
Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol (2001) 0.96